Premier Alternatives

Scipher Medicine

Discovery Tools (Healthcare) · Waltham, MA · Founded 2013 · Privately Held (backing)

Developer of diagnostics and a precision medicine platform designed for therapy selection and drug development in autoimmune diseases. Scipher Medicine is based in Waltham, MA and was founded in 2013. Its last known valuation is $496 million. It has raised $232 million across 6 recorded rounds; the latest was a $5.8 million early-stage round in May 2024.

Last price · $/share
—
Implied valuation
$495.9M
Total raised
$232.0M
Last round
Early Stage VC
May 2024

Scipher Medicine key facts

  • Developer of diagnostics and a precision medicine platform designed for therapy selection and drug development in autoimmune diseases.
  • Scipher Medicine’s last known valuation is $495.9M.
  • It has raised $232.0M across 6 recorded rounds; the latest was Early Stage VC ($5.8M) in May 2024.
  • Notable investors include Alumni Ventures, Khosla Ventures, Springboard Enterprises, Hitachi Ventures, Optum Ventures — 18 tracked in total.
  • Scipher Medicine has filed 7 Form Ds with the SEC since 2018, most recently Jul 2024 ($5.8M sold to 1 investors).
  • Status: Privately Held (backing).
Free account
More of Scipher Medicine with a free account
  • ·The complete investor list: 18 names
  • ·Watch Scipher Medicine: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Scipher Medicine funding rounds

6 rounds
May 2024Early Stage VC$5.8MSEC filing▮
Mar 2021Later Stage VC$82.0MSEC filing▮
May 2019Early Stage VC$25.0MSEC filing▮
Aug 2018Early Stage VC$8.5MSEC filing▮
May 2018Debt$795KSEC filing▮
Full funding history →

Scipher Medicine valuation

Scipher Medicine's last known valuation is $496 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How much has Scipher Medicine raised?

Scipher Medicine has raised $232 million across 6 recorded rounds since 2018. The largest was an $8.5 million early-stage round in Aug 2018; the most recent was a $5.8 million early-stage round in May 2024.

Scipher Medicine has filed 7 Form Ds with the SEC since 2018, most recently in Jul 2024 ($5.8 million sold to 1 investor).

Scipher Medicine investors

18 investors are on record for Scipher Medicine, including Alumni Ventures, Khosla Ventures, Springboard Enterprises and Hitachi Ventures. By type, the record holds 5 venture capital firms and 2 hedge funds. The early-stage round in May 2024 drew 1 investor.

Comparable companies

Comparable discovery tools (healthcare) names by valuation on PrivateMarketView: TRIANA Biomedicines ($258 million), Outpace Bio ($220 million) and Nature's Toolbox ($71 million).

About Scipher Medicine

Developer of diagnostics and a precision medicine platform designed for therapy selection and drug development in autoimmune diseases. The company's platform integrates large-scale molecular interaction maps, a proprietary AI engine, and a growing clinico-genomic dataset to identify patient-specific disease signatures, enabling healthcare professionals to predict treatment response, stratify patients, and accelerate precision drug discovery with clinical accuracy and efficiency.

Industry
Discovery Tools (Healthcare)
Sector
Healthcare
HQ
Waltham, MA, United States
Founded
2013
Employees
61
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.

Valuation on record
$495.9M

Scipher Medicine’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.